As the study investigators point out, however, quantifying and understanding the extent of this variation still represent important steps in better understanding cancer prognosis, as well as the development of new treatment strategies.
Dr. Taylor is associate professor in the department of internal medicine and director of adult clinical genetics at the University of Colorado at Denver. He reports having no conflicts of interest.